KCNH1: Difference between revisions

Jump to navigation Jump to search
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}))
 
m (Added hyperlinks)
Line 1: Line 1:
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{Infobox_gene}}
{{PBB_Controls
'''Potassium voltage-gated channel subfamily H member 1''' is a [[protein]] that in humans is encoded by the ''KCNH1'' [[gene]].<ref name="pmid9738473">{{cite journal |vauthors=Occhiodoro T, Bernheim L, Liu JH, Bijlenga P, Sinnreich M, Bader CR, Fischer-Lougheed J | title = Cloning of a human ether-a-go-go potassium channel expressed in myoblasts at the onset of fusion | journal = FEBS Lett | volume = 434 | issue = 1–2 | pages = 177–82 |date=Sep 1998 | pmid = 9738473 | pmc =  | doi =10.1016/S0014-5793(98)00973-9  }}</ref><ref name="pmid16382104">{{cite journal |vauthors=Gutman GA, Chandy KG, Grissmer S, Lazdunski M, McKinnon D, Pardo LA, Robertson GA, Rudy B, Sanguinetti MC, Stuhmer W, Wang X | title = International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels | journal = Pharmacol Rev | volume = 57 | issue = 4 | pages = 473–508 |date=Dec 2005 | pmid = 16382104 | pmc =  | doi = 10.1124/pr.57.4.10 }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: KCNH1 potassium voltage-gated channel, subfamily H (eag-related), member 1| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3756| accessdate = }}</ref>
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}
 
<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot.  See Template:PBB_Controls to Stop updates. -->
{{GNF_Protein_box
| image = 
| image_source = 
| PDB =
| Name = Potassium voltage-gated channel, subfamily H (eag-related), member 1
| HGNCid = 6250
| Symbol = KCNH1
| AltSymbols =; EAG; EAG1; Kv10.1; MGC142269; h-eag
| OMIM = 603305
| ECnumber = 
| Homologene = 68242
| MGIid = 1341721
| GeneAtlas_image1 = PBB_GE_KCNH1_207635_s_at_tn.png
| Function = {{GNF_GO|id=GO:0000155 |text = two-component sensor activity}} {{GNF_GO|id=GO:0005251 |text = delayed rectifier potassium channel activity}} {{GNF_GO|id=GO:0005516 |text = calmodulin binding}} {{GNF_GO|id=GO:0030955 |text = potassium ion binding}}
| Component = {{GNF_GO|id=GO:0005624 |text = membrane fraction}} {{GNF_GO|id=GO:0008076 |text = voltage-gated potassium channel complex}} {{GNF_GO|id=GO:0016020 |text = membrane}} {{GNF_GO|id=GO:0016021 |text = integral to membrane}}
  | Process = {{GNF_GO|id=GO:0000160 |text = two-component signal transduction system (phosphorelay)}} {{GNF_GO|id=GO:0006355 |text = regulation of transcription, DNA-dependent}} {{GNF_GO|id=GO:0006811 |text = ion transport}} {{GNF_GO|id=GO:0006813 |text = potassium ion transport}} {{GNF_GO|id=GO:0007520 |text = myoblast fusion}}
| Orthologs = {{GNF_Ortholog_box
    | Hs_EntrezGene = 3756
    | Hs_Ensembl = ENSG00000143473
    | Hs_RefseqProtein = NP_002229
    | Hs_RefseqmRNA = NM_002238
    | Hs_GenLoc_db =   
    | Hs_GenLoc_chr = 1
    | Hs_GenLoc_start = 208923178
    | Hs_GenLoc_end = 209374080
    | Hs_Uniprot = O95259
    | Mm_EntrezGene = 16510
    | Mm_Ensembl = ENSMUSG00000058248
    | Mm_RefseqmRNA = NM_001038607
    | Mm_RefseqProtein = NP_001033696
    | Mm_GenLoc_db = 
    | Mm_GenLoc_chr = 1
    | Mm_GenLoc_start = 193891596
    | Mm_GenLoc_end = 194210882
    | Mm_Uniprot = Q32MR6
  }}
}}
'''Potassium voltage-gated channel, subfamily H (eag-related), member 1''', also known as '''KCNH1''' or '''K<sub>v</sub>10.1''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: KCNH1 potassium voltage-gated channel, subfamily H (eag-related), member 1| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3756| accessdate = }}</ref>


<!-- The PBB_Summary template is automatically maintained by Protein Box Bot.  See Template:PBB_Controls to Stop updates. -->
<!-- The PBB_Summary template is automatically maintained by Protein Box Bot.  See Template:PBB_Controls to Stop updates. -->
{{PBB_Summary
{{PBB_Summary
| section_title =  
| section_title =  
| summary_text = Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a member of the potassium channel, voltage-gated, subfamily H. This member is a pore-forming (alpha) subunit of a voltage-gated non-inactivating delayed rectifier potassium channel. It is activated at the onset of myoblast differentiation. The gene is highly expressed in brain and in myoblasts. Overexpression of the gene may confer a growth advantage to cancer cells and favor tumor cell proliferation. Alternative splicing of this gene results in two transcript variants encoding distinct isoforms.<ref name="entrez">{{cite web | title = Entrez Gene: KCNH1 potassium voltage-gated channel, subfamily H (eag-related), member 1| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3756| accessdate = }}</ref>
| summary_text = Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a member of the potassium channel, voltage-gated, subfamily H. This member is a pore-forming (alpha) subunit of a voltage-gated non-inactivating delayed rectifier potassium channel. It is activated at the onset of myoblast differentiation. The gene is highly expressed in brain and in myoblasts. Overexpression of the gene may confer a growth advantage to cancer cells and favor tumor cell proliferation. Alternative splicing of this gene results in two transcript variants encoding distinct isoforms.<ref name="entrez" />
}}
}}
==Interactions==
KCNH1 has been shown to [[Protein-protein interaction|interact]] with [[KCNB1]].<ref name=pmid12060745>{{cite journal |last=Ottschytsch |first=N |authorlink= |author2=Raes A |author3=Van Hoorick D |author4=Snyders D J  |date=Jun 2002 |title=Obligatory heterotetramerization of three previously uncharacterized Kv channel α-subunits identified in the human genome |journal=[[PNAS|Proc. Natl. Acad. Sci. U.S.A.]] |volume=99 |issue=12 |pages=7986–91 |publisher= |location = United States| issn = 0027-8424| pmid = 12060745 |doi = 10.1073/pnas.122617999 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = |pmc=123007 }}</ref>
==Pathologies==
A recent study has shown that ''[[De novo mutation|de novo]]'' missense mutations in the ''KCNH1'' gene results in deleterious gain of function, resulting in a multisystem developmental disorder known as Temple-Baraitser syndrome (TBS). TBS is categorized by intellectual disabilities, epilepsy, and aplasia of the nails. Simons et al. suggested that mutational [[Mosaic (genetics)|mosaicism]] present in the mothers of some probands was responsible for their children's TBS phenotype. This is further evidence of the role that genetic mosaicism plays in the etiology of neurological disorders.<ref>{{Cite journal|last=Simons|first=Cas|last2=Rash|first2=Lachlan D.|last3=Crawford|first3=Joanna|last4=Ma|first4=Linlin|last5=Cristofori-Armstrong|first5=Ben|last6=Miller|first6=David|last7=Ru|first7=Kelin|last8=Baillie|first8=Gregory J.|last9=Alanay|first9=Yasemin|date=January 2015|title=Mutations in the voltage-gated potassium channel gene KCNH1 cause Temple-Baraitser syndrome and epilepsy|url=http://www.nature.com/ng/journal/v47/n1/full/ng.3153.html?foxtrotcallback=true|journal=Nature Genetics|language=en|volume=47|issue=1|pages=73–77|doi=10.1038/ng.3153|issn=1061-4036}}</ref>


==See also==
==See also==
Line 58: Line 18:


==References==
==References==
{{reflist|2}}
{{reflist}}


==Further reading==
==Further reading==
Line 64: Line 24:
{{PBB_Further_reading  
{{PBB_Further_reading  
| citations =  
| citations =  
*{{cite journal  | author=Gutman GA, Chandy KG, Grissmer S, ''et al.'' |title=International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. |journal=Pharmacol. Rev. |volume=57 |issue= 4 |pages= 473-508 |year= 2006 |pmid= 16382104 |doi= 10.1124/pr.57.4.10 }}
*{{cite journal  |vauthors=Warmke JW, Ganetzky B |title=A family of potassium channel genes related to eag in Drosophila and mammals |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=91 |issue= 8 |pages= 3438–42 |year= 1994 |pmid= 8159766 |doi=10.1073/pnas.91.8.3438  | pmc=43592 }}
*{{cite journal  | author=Warmke JW, Ganetzky B |title=A family of potassium channel genes related to eag in Drosophila and mammals. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=91 |issue= 8 |pages= 3438-42 |year= 1994 |pmid= 8159766 |doi=  }}
*{{cite journal   |vauthors=Hoshi N, Takahashi H, Shahidullah M, etal |title=KCR1, a membrane protein that facilitates functional expression of non-inactivating K+ currents associates with rat EAG voltage-dependent K+ channels |journal=J. Biol. Chem. |volume=273 |issue= 36 |pages= 23080–5 |year= 1998 |pmid= 9722534 |doi=10.1074/jbc.273.36.23080 }}
*{{cite journal | author=Hoshi N, Takahashi H, Shahidullah M, ''et al.'' |title=KCR1, a membrane protein that facilitates functional expression of non-inactivating K+ currents associates with rat EAG voltage-dependent K+ channels. |journal=J. Biol. Chem. |volume=273 |issue= 36 |pages= 23080-5 |year= 1998 |pmid= 9722534 |doi= }}
*{{cite journal   |vauthors=Pardo LA, del Camino D, Sánchez A, etal |title=Oncogenic potential of EAG K(+) channels |journal=EMBO J. |volume=18 |issue= 20 |pages= 5540–7 |year= 1999 |pmid= 10523298 |doi= 10.1093/emboj/18.20.5540 | pmc=1171622 }}
*{{cite journal  | author=Occhiodoro T, Bernheim L, Liu JH, ''et al.'' |title=Cloning of a human ether-a-go-go potassium channel expressed in myoblasts at the onset of fusion. |journal=FEBS Lett. |volume=434 |issue= 1-2 |pages= 177-82 |year= 1998 |pmid= 9738473 |doi= }}
*{{cite journal  |vauthors=Schönherr R, Löber K, Heinemann SH |title=Inhibition of human ether à go-go potassium channels by Ca2+/calmodulin |journal=EMBO J. |volume=19 |issue= 13 |pages= 3263–71 |year= 2000 |pmid= 10880439 |doi= 10.1093/emboj/19.13.3263 | pmc=313935 }}
*{{cite journal | author=Pardo LA, del Camino D, Sánchez A, ''et al.'' |title=Oncogenic potential of EAG K(+) channels. |journal=EMBO J. |volume=18 |issue= 20 |pages= 5540-7 |year= 1999 |pmid= 10523298 |doi= 10.1093/emboj/18.20.5540 }}
*{{cite journal  |vauthors=Cayabyab FS, Schlichter LC |title=Regulation of an ERG K+ current by Src tyrosine kinase |journal=J. Biol. Chem. |volume=277 |issue= 16 |pages= 13673–81 |year= 2002 |pmid= 11834728 |doi= 10.1074/jbc.M108211200 }}
*{{cite journal  | author=Schönherr R, Löber K, Heinemann SH |title=Inhibition of human ether à go-go potassium channels by Ca(2+)/calmodulin. |journal=EMBO J. |volume=19 |issue= 13 |pages= 3263-71 |year= 2000 |pmid= 10880439 |doi= 10.1093/emboj/19.13.3263 }}
*{{cite journal  |vauthors=Schönherr R, Gessner G, Löber K, Heinemann SH |title=Functional distinction of human EAG1 and EAG2 potassium channels |journal=FEBS Lett. |volume=514 |issue= 2–3 |pages= 204–8 |year= 2002 |pmid= 11943152 |doi=10.1016/S0014-5793(02)02365-7 }}
*{{cite journal  | author=Cayabyab FS, Schlichter LC |title=Regulation of an ERG K+ current by Src tyrosine kinase. |journal=J. Biol. Chem. |volume=277 |issue= 16 |pages= 13673-81 |year= 2002 |pmid= 11834728 |doi= 10.1074/jbc.M108211200 }}
*{{cite journal  |vauthors=Ottschytsch N, Raes A, Van Hoorick D, Snyders DJ |title=Obligatory heterotetramerization of three previously uncharacterized Kv channel α-subunits identified in the human genome |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 12 |pages= 7986–91 |year= 2002 |pmid= 12060745 |doi= 10.1073/pnas.122617999 | pmc=123007 }}
*{{cite journal  | author=Schönherr R, Gessner G, Löber K, Heinemann SH |title=Functional distinction of human EAG1 and EAG2 potassium channels. |journal=FEBS Lett. |volume=514 |issue= 2-3 |pages= 204-8 |year= 2002 |pmid= 11943152 |doi=  }}
*{{cite journal   |vauthors=Strausberg RL, Feingold EA, Grouse LH, etal |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 | pmc=139241 }}
*{{cite journal  | author=Ottschytsch N, Raes A, Van Hoorick D, Snyders DJ |title=Obligatory heterotetramerization of three previously uncharacterized Kv channel alpha-subunits identified in the human genome. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 12 |pages= 7986-91 |year= 2002 |pmid= 12060745 |doi= 10.1073/pnas.122617999 }}
*{{cite journal   |vauthors=Farias LM, Ocaña DB, Díaz L, etal |title=Ether a go-go potassium channels as human cervical cancer markers |journal=Cancer Res. |volume=64 |issue= 19 |pages= 6996–7001 |year= 2004 |pmid= 15466192 |doi= 10.1158/0008-5472.CAN-04-1204 }}
*{{cite journal | author=Strausberg RL, Feingold EA, Grouse LH, ''et al.'' |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899-903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 }}
*{{cite journal   |vauthors=Kang J, Chen XL, Wang H, etal |title=Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel |journal=Mol. Pharmacol. |volume=67 |issue= 3 |pages= 827–36 |year= 2005 |pmid= 15548764 |doi= 10.1124/mol.104.006577 }}
*{{cite journal | author=Farias LM, Ocaña DB, Díaz L, ''et al.'' |title=Ether a go-go potassium channels as human cervical cancer markers. |journal=Cancer Res. |volume=64 |issue= 19 |pages= 6996-7001 |year= 2004 |pmid= 15466192 |doi= 10.1158/0008-5472.CAN-04-1204 }}
*{{cite journal   |vauthors=Ziechner U, Schönherr R, Born AK, etal |title=Inhibition of human ether à go-go potassium channels by Ca2+/calmodulin binding to the cytosolic N- and C-termini |journal=FEBS J. |volume=273 |issue= 5 |pages= 1074–86 |year= 2006 |pmid= 16478480 |doi= 10.1111/j.1742-4658.2006.05134.x }}
*{{cite journal | author=Kang J, Chen XL, Wang H, ''et al.'' |title=Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel. |journal=Mol. Pharmacol. |volume=67 |issue= 3 |pages= 827-36 |year= 2005 |pmid= 15548764 |doi= 10.1124/mol.104.006577 }}
*{{cite journal   |vauthors=Weber C, Mello de Queiroz F, Downie BR, etal |title=Silencing the activity and proliferative properties of the human EagI Potassium Channel by RNA Interference |journal=J. Biol. Chem. |volume=281 |issue= 19 |pages= 13030–7 |year= 2006 |pmid= 16537547 |doi= 10.1074/jbc.M600883200 }}
*{{cite journal | author=Ziechner U, Schönherr R, Born AK, ''et al.'' |title=Inhibition of human ether à go-go potassium channels by Ca2+/calmodulin binding to the cytosolic N- and C-termini. |journal=FEBS J. |volume=273 |issue= 5 |pages= 1074-86 |year= 2006 |pmid= 16478480 |doi= 10.1111/j.1742-4658.2006.05134.x }}
*{{cite journal  |vauthors=Mello de Queiroz F, Suarez-Kurtz G, Stühmer W, Pardo LA |title=Ether à go-go potassium channel expression in soft tissue sarcoma patients |journal=Mol. Cancer |volume=5 |issue=  |pages= 42 |year= 2006 |pmid= 17022811 |doi= 10.1186/1476-4598-5-42 | pmc=1618397 }}
*{{cite journal | author=Weber C, Mello de Queiroz F, Downie BR, ''et al.'' |title=Silencing the activity and proliferative properties of the human EagI Potassium Channel by RNA Interference. |journal=J. Biol. Chem. |volume=281 |issue= 19 |pages= 13030-7 |year= 2006 |pmid= 16537547 |doi= 10.1074/jbc.M600883200 }}
*{{cite journal   |vauthors=Ocorr K, Reeves NL, Wessells RJ, etal |title=KCNQ potassium channel mutations cause cardiac arrhythmias in Drosophila that mimic the effects of aging |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=104 |issue= 10 |pages= 3943–8 |year= 2007 |pmid= 17360457 |doi= 10.1073/pnas.0609278104 | pmc=1820688 }}
*{{cite journal  | author=Mello de Queiroz F, Suarez-Kurtz G, Stühmer W, Pardo LA |title=Ether à go-go potassium channel expression in soft tissue sarcoma patients. |journal=Mol. Cancer |volume=5 |issue=  |pages= 42 |year= 2006 |pmid= 17022811 |doi= 10.1186/1476-4598-5-42 }}
*{{cite journal   |vauthors=Ding XW, Yan JJ, An P, etal |title=Aberrant expression of ether à go-go potassium channel in colorectal cancer patients and cell lines |journal=World J. Gastroenterol. |volume=13 |issue= 8 |pages= 1257–61 |year= 2007 |pmid= 17451210 |doi=  10.3748/wjg.v13.i8.1257}}
*{{cite journal | author=Ocorr K, Reeves NL, Wessells RJ, ''et al.'' |title=KCNQ potassium channel mutations cause cardiac arrhythmias in Drosophila that mimic the effects of aging. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=104 |issue= 10 |pages= 3943-8 |year= 2007 |pmid= 17360457 |doi= 10.1073/pnas.0609278104 }}
*{{cite journal   |vauthors=Borowiec AS, Hague F, Harir N, etal |title=IGF-1 activates hEAG K(+) channels through an Akt-dependent signaling pathway in breast cancer cells: role in cell proliferation |journal=J. Cell. Physiol. |volume=212 |issue= 3 |pages= 690–701 |year= 2007 |pmid= 17520698 |doi= 10.1002/jcp.21065 }}
*{{cite journal | author=Ding XW, Yan JJ, An P, ''et al.'' |title=Aberrant expression of ether à go-go potassium channel in colorectal cancer patients and cell lines. |journal=World J. Gastroenterol. |volume=13 |issue= 8 |pages= 1257-61 |year= 2007 |pmid= 17451210 |doi=  }}
*{{cite journal | author=Borowiec AS, Hague F, Harir N, ''et al.'' |title=IGF-1 activates hEAG K(+) channels through an Akt-dependent signaling pathway in breast cancer cells: role in cell proliferation. |journal=J. Cell. Physiol. |volume=212 |issue= 3 |pages= 690-701 |year= 2007 |pmid= 17520698 |doi= 10.1002/jcp.21065 }}
}}
}}
{{refend}}
{{refend}}
Line 87: Line 45:
== External links ==
== External links ==
* {{MeshName|KCNH1+protein,+human}}
* {{MeshName|KCNH1+protein,+human}}
{{NLM content}}
{{Ion channels|g3}}
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{PBB_Controls
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}


{{membrane-protein-stub}}
{{membrane-protein-stub}}
{{NLM content}}
 
{{Ion channels}}
[[Category:PAS-domain-containing proteins]]
{{WikiDoc Sources}}

Revision as of 15:09, 4 October 2017

VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

Potassium voltage-gated channel subfamily H member 1 is a protein that in humans is encoded by the KCNH1 gene.[1][2][3]

Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a member of the potassium channel, voltage-gated, subfamily H. This member is a pore-forming (alpha) subunit of a voltage-gated non-inactivating delayed rectifier potassium channel. It is activated at the onset of myoblast differentiation. The gene is highly expressed in brain and in myoblasts. Overexpression of the gene may confer a growth advantage to cancer cells and favor tumor cell proliferation. Alternative splicing of this gene results in two transcript variants encoding distinct isoforms.[3]

Interactions

KCNH1 has been shown to interact with KCNB1.[4]

Pathologies

A recent study has shown that de novo missense mutations in the KCNH1 gene results in deleterious gain of function, resulting in a multisystem developmental disorder known as Temple-Baraitser syndrome (TBS). TBS is categorized by intellectual disabilities, epilepsy, and aplasia of the nails. Simons et al. suggested that mutational mosaicism present in the mothers of some probands was responsible for their children's TBS phenotype. This is further evidence of the role that genetic mosaicism plays in the etiology of neurological disorders.[5]

See also

References

  1. Occhiodoro T, Bernheim L, Liu JH, Bijlenga P, Sinnreich M, Bader CR, Fischer-Lougheed J (Sep 1998). "Cloning of a human ether-a-go-go potassium channel expressed in myoblasts at the onset of fusion". FEBS Lett. 434 (1–2): 177–82. doi:10.1016/S0014-5793(98)00973-9. PMID 9738473.
  2. Gutman GA, Chandy KG, Grissmer S, Lazdunski M, McKinnon D, Pardo LA, Robertson GA, Rudy B, Sanguinetti MC, Stuhmer W, Wang X (Dec 2005). "International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels". Pharmacol Rev. 57 (4): 473–508. doi:10.1124/pr.57.4.10. PMID 16382104.
  3. 3.0 3.1 "Entrez Gene: KCNH1 potassium voltage-gated channel, subfamily H (eag-related), member 1".
  4. Ottschytsch, N; Raes A; Van Hoorick D; Snyders D J (Jun 2002). "Obligatory heterotetramerization of three previously uncharacterized Kv channel α-subunits identified in the human genome". Proc. Natl. Acad. Sci. U.S.A. United States. 99 (12): 7986–91. doi:10.1073/pnas.122617999. ISSN 0027-8424. PMC 123007. PMID 12060745.
  5. Simons, Cas; Rash, Lachlan D.; Crawford, Joanna; Ma, Linlin; Cristofori-Armstrong, Ben; Miller, David; Ru, Kelin; Baillie, Gregory J.; Alanay, Yasemin (January 2015). "Mutations in the voltage-gated potassium channel gene KCNH1 cause Temple-Baraitser syndrome and epilepsy". Nature Genetics. 47 (1): 73–77. doi:10.1038/ng.3153. ISSN 1061-4036.

Further reading

External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.